Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Paskalium — PASKALIUM
Application NDA009395 (NDA)
Paskalium — PARASAL SODIUM
Application NDA006811 (NDA)
Paskalium — TEEBACIN
Application NDA007320 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)